Medical therapy for rheumatic heart disease: Is it time to be proactive rather than reactive?

Nalini M. Rajamannan, Francesco Antonini-Canterin, Luis Moura, José L. Zamorano, Raphael A. Rosenhek, Patricia J.M. Best, Margaret A. Lloyd, F. Rocha-Gonçalves, Sarat Chandra, Ottavio Alfieri, Patrizio Lancellotti, Pilar Tornos, Ragavendra R. Baliga, Andrew Wang, Thomas Bashore, S. Ramakrishnan, Konstantinos Spargias, Mony Shuvy, Ronen Beeri, Chaim LotanJassim Al Suwaidi, Vinay Bahl, Luc A. Pierard, Gerald Maurer, Gian Luigi Nicolosi, Shahbudin H. Rahimtoola, H. K. Chopra, Natesa G. Pandian

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Medical therapy for rheumatic heart disease: Is it time to be proactive rather than reactive?'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions